Back to search
Pre-emptive
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pre-emptive trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pre-emptive trials you may qualify forSHIELD is a single-center, open-label, single-arm prospective study designed to evaluate whether pre-emptive topical indomethacin can reduce sorafenib-associate…
It is known that individuals respond differently to the same medicine with some people benefitting, some experiencing no effect and others suffering side-effect…
Evaluate the safety and efficacy of postoperative Pre-emptive EVT (PEVT) in reducing the incidence of anastomotic leaks within 30 days after surgery in patients…
The investigators hypothesize that early measurable residual disease (MRD)-guided pre-emptive therapy with decitabine + cedazaridine (DEC-C) will decrease the r…
Clostridioides difficile (C. difficile) is the most common healthcare-associated pathogen, causing \>500,000 infections and \>29,000 deaths per year in the US.…
This phase II trial compares the effect of belumosudil to a placebo in treating patients with chronic graft versus host disease. Chronic graft versus host disea…
A study to evaluate the safety and tolerability of opelconazole for the prevention of fungal aspergillus infections in the lung in participants who have receive…
To demonstrate the efficacy of targeted and tailored sequential therapy in patients with AML.
The PREP-ANCA study seeks to establish a more personalized treatment strategy for ANCA-associated vasculitides by assessing the efficacy of pre-emptive rituxima…